晚期胆道癌的第一线全身疗法和测序选项:系统性审查和网络元分析
Ranning Xu1, Jian Zhou2, Jian Yang1
1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Bioscience trends
|December 8, 2024
概括
关于晚期胆道癌症 (BTC) 的新研究表明,包括免疫疗法在内的三重疗法,如杜尔瓦卢马布 (durvalumab) 加上吉姆西塔宾 (gemcitabine) 和西斯普拉丁 (cisplatin),与标准化疗相比,可以改善无进展生存率和整体生存率.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
- 临床试验 临床试验
背景情况:
- 晚期胆道癌 (BTC) 治疗格局正在发展.
- 在先进的BTC中缺乏一线全身疗法的直接比较试验.
研究的目的:
- 系统地审查和分析第3期临床试验的第一线全身疗法疗效在先进的BTC.
- 用网络元分析比较各种一线治疗方案.
主要方法:
- 在遵守PRISMA指南的基础上进行系统审查.
- 包括七个低偏差风险的第三期临床试验.
- 网络对4033名患者的数据进行了元分析.
主要成果:
- 杜尔瓦卢马布 + 凝丁 + 西斯普拉丁 (GemCis),S-1 + 凝丁,布罗利祖马布 + 凝丁三重疗法比凝丁的无进展生存率 (PFS) 高.
- 与GemCis相比,Durvalumab + GemCis和pembrolizumab + GemCis三重疗法证明了整体存活率 (OS) 的改善.
- 杜尔瓦卢马布+GemCis在PFS中排名最高,在OS中排名第二.
结论:
- 分子免疫疗法组合在高级BTC的第一线治疗中提供了显著的好处.
- 未来的研究应该探索BTC的新组合和分子免疫向疗法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


